PBM Reform Podcast: What Other States Can Learn From Iowa’s PBM Reform Law
Iowa’s PBM reform fight shows how pharmacists can help shape policy, build legislative support, and defend reforms after they become law.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
APCI tracks and reports on pharmacy public policy developments, including PBM reform efforts, legislative activity, and regulatory changes impacting independent pharmacies.
Iowa’s PBM reform fight shows how pharmacists can help shape policy, build legislative support, and defend reforms after they become law.
TRICARE’s shrinking pharmacy network raises questions about patient choice, rural access, and whether current standards truly measure meaningful pharmacy access.
H.R. 6610 has cleared committee with overwhelming bipartisan support. Now independent pharmacy needs Congress to keep the Pharmacists Fight Back Act moving.
The Pharmacists Fight Back Act applies to one federal health program. If successful, it could become a model for broader pharmacy benefit manager reform efforts.
The House Oversight Committee advanced the Pharmacists Fight Back Act on a bipartisan 40–2 vote, moving H.R. 6610 one step closer to consideration by the full House.
APCI’s Greg Reybold called for greater transparency and independent oversight of the TRICARE pharmacy program during a Senate hearing. Watch key exchanges on Express Scripts, community pharmacy access, mail-order costs, and the need for an independent audit.
In prepared remarks submitted before his Senate testimony, Reybold called for an independent audit of the TRICARE pharmacy program and reforms to protect beneficiary choice and community pharmacy access.
The co-op's vice president of healthcare policy will provide expert testimony on PBM practices during a July 15 Armed Services committee hearing examining the TRICARE Pharmacy Program.
Lawmakers in Tennessee are targeting PBM pharmacy ownership and reimbursement practices. Here’s how the legislation could reshape competition, patient access, and independent pharmacy viability.
A congressional hearing pulls back the curtain on vertically integrated healthcare and the control driving higher costs, limited access, and fewer choices for patients and pharmacists.